Sermorelin acetate (INN ; brand names Geref, Gerel), also known as GHRH (1-29), is a peptide analogue of growth hormone-releasing hormone (GHRH) which is used as a diagnostic agent to assess growth hormone (GH) secretion for the purpose of diagnosing growth hormone deficiency. It is a 29-amino acid polypeptide representing the 1–29 fragment from endogenous human GHRH, thought to be the shortest fully functional fragment of GHRH.[1][2]
Clinical data | |
---|---|
Trade names | Geref, Gerel |
Other names | GRF 1–29 |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Routes of administration | Injection |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
DrugBank |
|
ChemSpider |
|
UNII |
|
KEGG |
|
ChEBI |
|
ChEMBL |
|
CompTox Dashboard (EPA) |
|
Chemical and physical data | |
Formula | C149H246N44O42S |
Molar mass | 3357.93 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(what is this?) (verify) |